Genetic and lifestyle variables associated with homocysteine concentrations and the distribution of folate derivatives in healthy premenopausal women

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 88, Issue 8, 2010, Pages 679-688

  Summers, Carolyn M ^a   Mitchell, Laura E ^b   Stanislawska Sachadyn, Anna ^a   Baido, Shirley F ^a,c   Blair, Ian A ^a   Von Feldt, Joan M ^a   Whitehead, Alexander S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c LINCOLN UNIVERSITY   (United States)

Author keywords

Folate; Genetics; Homocysteine; Reproductive age; Spina bifida risk; Women

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID DERIVATIVE; HOMOCYSTEINE; METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE; METHIONINE SYNTHASE; REDUCED FOLATE CARRIER; TETRAHYDROFOLIC ACID; THYMIDYLATE SYNTHASE;

ADULT; AFRICAN AMERICAN; ARTICLE; BIOCHEMICAL COMPOSITION; BLOOD SAMPLING; CAUCASIAN; CIGARETTE SMOKING; ERYTHROCYTE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; ISOTOPE DILUTION ASSAY; LIFESTYLE MODIFICATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHENOTYPE; PREMENOPAUSE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; VITAMIN SUPPLEMENTATION;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADOLESCENT; ADULT; AFRICAN AMERICANS; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; ERYTHROCYTES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; HOMOCYSTEINE; HUMANS; INFANT; LIFE STYLE; MEMBRANE TRANSPORT PROTEINS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; PREGNANCY; PREMENOPAUSE; SPINAL DYSRAPHISM; TETRAHYDROFOLATES; THYMIDYLATE SYNTHASE; VITAMINS; YOUNG ADULT;

EID: 77955620303     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20683     Document Type: Article

References (62)

1. Bagley PJ, Selhub J. 1998. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci USA 95:13217-13220.
2. Berry RJ, Li Z, Erickson JD, et al. 1999. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341:1485-1490.
3. Botto LD, Yang Q. 2000. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151:862-877.
4. Brody LC, Conley M, Cox C, et al. 2002. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/ methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet 71:1207-1215.
5. Brown KS, Kluijtmans LA, Young IS, et al. 2004a. The thymidylate synthase tandem repeat polymorphism is not associated with homocysteine concentrations in healthy young subjects. Hum Genet 114:182-185.
6. Brown KS, Kluijtmans LA, Young IS, et al. 2004b. The 5,10- methylenetetrahydrofolate reductase C677T polymorphism interacts with smoking to increase homocysteine. Atherosclerosis 174:315-322.
7. Bukowski R, Malone FD, Porter FT, et al. 2009. Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study. PLoS Med 6:e1000061.
8. Chen J, Stampfer MJ, Ma J, et al. 2001. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis 154:667-672.
9. Czeizel AE. 1998. Periconceptional folic acid containing multivitamin supplementation. Eur J Obstet Gynecol Reprod Biol 78:151-161.
10. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neuraltube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
11. De Marco P, Calevo MG, Moroni A, et al. 2003. Reduced folate carrier polymorphism (80A->G) and neural tube defects. Eur J Hum Genet 11:245-252.
12. Doolin MT, Barbaux S, McDonnell M, et al. 2002. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet 71:1222-1226.
13. D'Uva M, Di Micco P, Strina I, et al. 2007. Hyperhomocysteinemia in women with unexplained sterility or recurrent early pregnancy loss from Southern Italy: a preliminary report. Thromb J 5:10.
14. Eskenazi B, Fenster L, Sidney S, et al. 1991. A multivariate analysis of risk factors for preeclampsia. JAMA 266:237-241.
15. Feuchtbaum LB, Currier RJ, Riggle S, et al. 1999. Neural tube defect prevalence in California (1990-1994): eliciting patterns by type of defect and maternal race/ethnicity. Genet Test 3:265-272.
16. Gabriel HE, Crott JW, Ghandour H, et al. 2006. Chronic cigarette smoking is associated with diminished folate status, altered folate form distribution, and increased genetic damage in the buccal mucosa of healthy adults. Am J Clin Nutr 83:835-841.
17. Gaughan DJ, Kluijtmans LA, Barbaux S, et al. 2001. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157:451-456.
18. Gaughan DJ, Kluijtmans LA, Barbaux S, et al. 2002. Corrigendum to "The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations." [Atherosclerosis 157(2001):451-456]. 167:373.
19. Harmon DL, Shields DC, Woodside JV, et al. 1999. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 17:298-309.
20. Harmon DL, Woodside JV, Yarnell JW, et al. 1996. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM 89:571-577.
21. Heron M, Sutton PD, Xu J, et al. 2010. Annual summary of vital statistics: 2007. Pediatrics 125:4-15.
22. Honein MA, Paulozzi LJ, Mathews TJ, et al. 2001. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285:2981-2986.
23. Huang Y, Khartulyari S, Morales ME, et al. 2008. Quantification of key red blood cell folates from subjects with defined MTHFR 677C>T genotypes using stable isotope dilution liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 22:2403-2412.
24. Huang Y, Lu ZY, Brown KS, et al. 2007. Quantification of intracellular homocysteine by stable isotope dilution liquid chromatography/tandem mass spectrometry. Biomed Chromatogr 21:107-112.
25. Jacques PF, Bostom AG, Williams RR, et al. 1996. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7-9.
26. Jacques PF, Selhub J, Bostom AG, et al. 1999. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 340:1449-1454.
27. James SJ, Pogribna M, Pogribny IP, et al. 1999. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 70:495-501.
28. Johnson WG, Stenroos ES, Spychala JR, et al. 2004. New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? Am J Med Genet A 124:339-345.
29. Kang SS, Wong PW, Norusis M, et al. 1987. Homocysteinemia due to folate deficiency. Metabolism 36:458-462.
30. Kealey C, Brown KS, Woodside JV, et al. 2005. A common insertion/deletion polymorphism of the thymidylate synthase (TYMS) gene is a determinant of red blood cell folate and homocysteine concentrations. Hum Genet 116:347-353.
31. Kirke PN, Mills JL, Molloy AM, et al. 2004. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study. BMJ 328:1535-1536.
32. Konstantinova SV, Vollset SE, Berstad P, et al. 2007. Dietary predictors of plasma total homocysteine in the Hordaland Homocysteine Study. Br J Nutr 98:201-210.
33. Little J, Gilmour M, Mossey PA, et al. 2008. Folate and clefts of the lip and palate: a U.K.-based case-control study. Part II: Biochemical and genetic analysis. Cleft Palate Craniofac J 45:428-438.
34. Lu ZY, Morales M, Khartulyari S, et al. 2008. Genetic and biochemical determinants of serum concentrations of monocyte chemoattractant protein-1, a potential neural tube defect risk factor. Birth Defects Res A Clin Mol Teratol 82:736-741.
35. Lucock M. 2000. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 71:121-138.
36. Meyer MB, Jonas BS, Tonascia JA, et al. 1976. Perinatal events associated with maternal smoking during pregnancy. Am J Epidemiol 103:464-476.
37. Mitchell LE, Adzick NS, Melchionne J, et al. 2004. Spina bifida. Lancet 364:1885-1895.
38. Molloy AM, Mills JL, Kirke PN, et al. 1998. Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10- methylenetetrahydrofolate reductase: low folate status alone may be the critical factor. Am J Med Genet 78:155-159.
39. Morin I, Devlin AM, Leclerc D, et al. 2003. Evaluation of genetic variants in the reduced folate carrier and in glutamate carboxypeptidase II for spina bifida risk. Mol Genet Metab 79:197-200.
40. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131-137.
41. Parle-McDermott A, Kirke PN, Mills JL, et al. 2006. Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population. Eur J Hum Genet 14:768-772.
42. Selhub J, Jacques PF, Wilson PW, et al. 1993. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693-2698.
43. Skibola CF, Forrest MS, Coppede F, et al. 2004. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 104:2155-2162.
44. Skibola CF, Smith MT, Hubbard A, et al. 2002. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 99:3786-3791.
45. Stanislawska-Sachadyn A, Brown KS, Mitchell LE, et al. 2008a. An insertion/deletion polymorphism of the dihydrofolate reductase (DHFR) gene is associated with serum and red blood cell folate concentrations in women. Hum Genet 123:289-295.
46. Stanislawska-Sachadyn A, Mitchell LE, Woodside JV, et al. 2009. The reduced folate carrier (SLC19A1) c. 80G>A polymorphism is associated with red cell folate concentrations among women. Ann Hum Genet 73:484-491.
47. Stanislawska-Sachadyn A, Woodside JV, Brown KS, et al. 2008b. Evidence for sex differences in the determinants of homocysteine concentrations. Mol Genet Metab 93:355-362.
48. Stover PJ. 2004. Physiology of folate and vitamin B12 in health and disease. Nutr Rev 62:S3-12; discussion S13.
49. Summers CM, Cucchiara AJ, Nackos E, et al. 2008. Functional polymorphisms of folate-metabolizing enzymes in relation to homocysteine concentrations in systemic lupus erythematosus. J Rheumatol 35:2179-2186.
50. Thuesen BH, Husemoen LL, Ovesen L, et al. 2010. Lifestyle and genetic determinants of folate and vitamin B12 levels in a general adult population. Br J Nutr 103:1195-1204.
51. Timmermans S, Jaddoe VW, Hofman A, et al. 2009. Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study. Br J Nutr 102:777-785.
52. Trinh BN, Ong CN, Coetzee GA, et al. 2002. Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet 111:299-302.
53. Tsai MY, Bignell M, Yang F, et al. 2000. Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels. Atherosclerosis 149:131-137.
54. Ulvik A, Ueland PM, Fredriksen A, et al. 2007. Functional inference of the methylenetetrahydrofolate reductase 677C>T and 1298A>C polymorphisms from a large-scale epidemiological study. Hum Genet 121:57-64.
55. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
56. Volcik KA, Shaw GM, Zhu H, et al. 2003. Associations between polymorphisms within the thymidylate synthase gene and spina bifida. Birth Defects Res A Clin Mol Teratol 67:924-928. (Pubitemid 37484708)
57. Vollset SE, Refsum H, Irgens LM, et al. 2000. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr 71:962-968.
58. Whitehead AS, Gallagher P, Mills JL, et al. 1995. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM 88:763-766.
59. Williams LJ, Mai CT, Edmonds LD, et al. 2002. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66:33-39.
60. Wilson A, Platt R, Wu Q, et al. 1999. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 67:317-323.
61. Wyszynski DF, Duffy DL, Beaty TH, et al. 1997. Maternal cigarette smoking and oral clefts: a meta-analysis. Cleft Palate Craniofac J 34:206-210.
62. Yang Q, Khoury MJ, Olney RS, et al. 1997. Does periconceptional multivitamin use reduce the risk for limb deficiency in offspring? Epidemiology 8:157-161.